A new approach for generating bispecific antibodies based on a common light chain format and the stable architecture of human immunoglobulin G1.
about
Opposites attract in bispecific antibody engineering.Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics.Development and clinical application of anti-HER2 monoclonal and bispecific antibodies for cancer treatment.Expanding the Boundaries of Biotherapeutics with Bispecific AntibodiesPerspectives for the Development of CD38-Specific Heavy Chain Antibodies as Therapeutics for Multiple Myeloma
P2860
A new approach for generating bispecific antibodies based on a common light chain format and the stable architecture of human immunoglobulin G1.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
A new approach for generating ...... re of human immunoglobulin G1.
@en
type
label
A new approach for generating ...... re of human immunoglobulin G1.
@en
prefLabel
A new approach for generating ...... re of human immunoglobulin G1.
@en
P2093
P2860
P356
P1476
A new approach for generating ...... re of human immunoglobulin G1.
@en
P2093
Alexander B H Bakker
Camilla De Nardis
Emilie Poirier
John de Kruif
Linda J A Hendriks
Tudor Arvinte
P2860
P304
14706-14717
P356
10.1074/JBC.M117.793497
P407
P577
2017-06-27T00:00:00Z